Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidia…
- REGENERATE-PD, which is now enrolling, will study AB-1005, an adeno-associated virus 2 (AAV2) glial cell line-deriv…
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in th…
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today anno…
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidia…
- Restructuring Provides Parallel Rights to Manufacture and Sell doggybone DNA (dbDNA™) into the AAV market as Independe…
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced…
Digium®, Inc., the Asterisk® Company and Ascom Wireless Solutions, a leading provider of on-site wireless communications…
IBM (NYSE: IBM) announced today plans to build a $360 million state-of-the-art data center at its facility in Research T…
DuPont Electronic Technologies erhöht zum 16. Juni weltweit die Preise um bis zu 20 Prozent. DuPont Electronic Technolog…
